Summary:
ZuvaSyntha is developing proprietary renewable manufacturing routes to industrial chemicals from low cost feedstocks such as syngas and methanol.
Its lead program…
read moreStaying agile in early-stage deep technology companies
Investing in UK Space Technology
Virtual business: completing a merger online
Supporting UK agritech innovation
Ikarovec named as one of Scrip’s ‘10 To Watch’
Synthetic Biology start up NanoSyrinx secures capital to develop its fully customisable platform for intra-cellular engineering
AgPlus Diagnostics wins £230,000 in UK Government grants for COVID-19 diagnostic test development
Atelerix awarded Innovate UK funding to enable transport and storage of cellular therapies at room temperature
Tips for first-time fundraising
From academia to start-up: how to build a successful spin-out
Financial management in a crisis: how can early stage technology companies survive a pandemic
The Role of Public-Private Partnerships in the Future of Fusion Energy
MicrofluidX raises £1.4m in seed funding to develop novel cell therapy bioprocessing technology
New analysis confirms value of UKI2S investing public money to commercialise public science
How to build a start-up: Launching early stage science companies
Summary:
ZuvaSyntha is developing proprietary renewable manufacturing routes to industrial chemicals from low cost feedstocks such as syngas and methanol.
Its lead program…
read more